Synopsis of recent research by authors named "Chan-Hi Joung"
- Chan-Hi Joung's research primarily focuses on the development and characterization of recombinant proteins, particularly exploring fusion proteins to enhance their therapeutic properties.
- In a study published in December 2009, Joung successfully produced a long-acting recombinant human albumin-EPO fusion protein using CHO cells, demonstrating the potential for improved efficacy in clinical applications.
- The research revealed that the albumin-EPO fusion protein can exist in three sub-types and incorporated a repeated linker sequence to enhance the stability and longevity of the therapeutic protein.
